Medical Weight Loss · Spring, TX
Tirzepatide for Weight Loss
The newest dual-action GLP-1 + GIP weight loss medication — clinically proven to help patients lose up to 22% of their body weight. Available via telehealth at Revive Wellness Center.
What Is Tirzepatide?
Tirzepatide is a once-weekly injectable medication that activates two hormone receptors — GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual mechanism sets it apart from semaglutide, which targets GLP-1 alone.
Originally approved for type 2 diabetes as Mounjaro®, tirzepatide received FDA approval for chronic weight management in November 2023 under the brand name Zepbound®. It is now one of the most effective prescription weight loss medications available.
At Revive Wellness Center, our providers prescribe tirzepatide as part of a personalized, physician-supervised weight loss program — accessible entirely through telehealth.
Tirzepatide vs. Semaglutide
| Feature | Tirzepatide | Semaglutide |
|---|---|---|
| Mechanism | Dual GIP + GLP-1 | GLP-1 only |
| Brand names | Zepbound®, Mounjaro® | Wegovy®, Ozempic® |
| Avg. weight loss | Up to 22.5% | Up to 17% |
| Dosing | Once weekly injection | Once weekly injection |
| FDA approval (weight) | 2023 | 2021 |
Both medications are effective. Your Revive Wellness provider will help you choose the right option based on your health history, goals, and insurance coverage.
Who Qualifies for Tirzepatide?
- BMI of 30 or higher (obesity)
- BMI of 27 or higher with a weight-related condition (type 2 diabetes, hypertension, high cholesterol, sleep apnea)
- Adults who have not achieved adequate weight loss with diet and exercise alone
- Patients who tried semaglutide and want to explore a more potent option
- No personal or family history of medullary thyroid carcinoma or MEN2 syndrome
Frequently Asked Questions
See If Tirzepatide Is Right for You
Book a telehealth consultation with a Revive Wellness provider. Same-day appointments available in Spring, TX.